VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
DBD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
DBDDiebold Nixdorf, Incorporated
$63.04$2.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDBDFinancials

Diebold Nixdorf, Incorporated (DBD) Income Statement

30Y historyFree accessUpdated daily

Revenue growth remains subdued at 1.7% YoY in Q2 2026, but gross margin improved to 25.7% and operating margin reached 6.2%, though Q4 2025's 11.6% operating margin appears to be an outlier.

Income StatementBalance SheetCash FlowRatios

DBD Income Statement

Annual statement

DBD Income Statement

Diebold Nixdorf, Incorporated (DBD) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue3.87B3.81B3.75B3.76B3.46B3.91B3.9B4.41B4.58B4.61B3.32B2.42B3.05B2.86B2.99B2.84B2.82B2.72B3.17B2.96B2.91B2.59B2.38B2.11B1.94B1.76B1.74B1.26B1.19B1.23B1.03B
Revenue Growth %5.44%1.46%-0.25%8.66%-11.38%0.07%-11.48%-3.72%-0.67%38.99%37.08%-20.71%6.77%-4.49%5.5%0.43%3.88%-14.25%6.92%2.02%12.34%8.66%12.86%8.74%10.22%0.96%38.47%6.2%-3.36%19.09%19.32%
Cost of Goods Sold2.86B2.8B2.83B2.88B2.7B2.86B2.87B3.33B3.69B3.58B2.57B1.76B2.27B2.22B2.26B2.1B2.1B2.07B2.38B2.28B2.2B1.96B1.7B1.48B1.35B1.24B1.15B767.7M744M768.4M639.3M
COGS % of Revenue-73.63%75.47%76.7%78.12%73.28%73.48%75.58%80.54%77.68%77.47%72.86%74.46%77.59%75.39%74.05%74.52%76.09%74.93%76.93%75.55%75.82%71.51%70.27%69.35%70.23%65.87%60.97%62.75%62.63%62.06%
Gross Profit1.01B1B920M876.2M757.3M1.04B1.03B1.08B890.9M1.03B747.2M656.5M779.35M640.36M736.15M735.93M719.57M650M794.62M683.85M710.52M625.48M678.38M627.14M594.64M524.07M595.06M491.5M441.7M458.5M390.9M
Gross Margin %26.15%26.37%24.53%23.3%21.88%26.72%26.52%24.42%19.46%22.32%22.53%27.14%25.54%22.41%24.61%25.95%25.48%23.91%25.07%23.07%24.45%24.18%28.49%29.73%30.65%29.77%34.13%39.03%37.25%37.37%37.94%
Gross Profit Growth %-9.07%5%15.7%-27.42%0.81%-3.85%20.82%-13.42%37.71%13.82%-15.76%21.71%-13.01%0.03%2.27%10.7%-18.2%16.2%-3.75%13.6%-7.8%8.17%5.47%13.47%-11.93%21.07%11.27%-3.66%17.29%20.69%
Operating Expenses695.8M668.8M737.9M789.3M969M906.3M1.01B841.4M1.04B893.6M686.7M522.1M609.17M689.01M595.66M577.37M545.52M496.91M618.34M584.49M534.86M464.21M401.41M364.29M353.47M385.16M366.1M306.6M274.3M274.7M250.6M
OpEx % of Revenue-17.57%19.67%20.99%28%23.21%25.91%19.09%22.78%19.39%20.71%21.58%19.97%24.11%19.91%20.36%19.32%18.28%19.51%19.71%18.4%17.94%16.86%17.27%18.22%21.88%21%24.35%23.13%22.39%24.33%
Selling, General & Admin470.6M585M643.6M0741.6M775.6M858.6M697.3M885.6M737M581.6M435.8M515.55M596.69M509.78M499.26M471.29M424.88M534.49M470.62M463.86M403.8M341.39M303.84M289.58M325.54M274.51M221.4M194.5M191.8M217.6M
SG&A % of Revenue-15.37%17.16%-21.43%19.86%22%15.82%19.34%15.99%17.54%18.01%16.9%20.88%17.04%17.61%16.69%15.63%16.86%15.87%15.96%15.61%14.34%14.4%14.93%18.49%15.74%17.58%16.4%15.63%21.12%
Research & Development83.9M83.8M93.6M110.9M120.7M126.3M133.4M144.1M157.4M156.6M105.1M86.3M93.62M92.31M85.88M78.11M74.22M72.03M79.07M73.95M71M60.41M60.02M60.45M63.89M59.61M55.69M50.5M54.2M54.4M0
R&D % of Revenue-2.2%2.5%2.95%3.49%3.23%3.42%3.27%3.44%3.4%3.17%3.57%3.07%3.23%2.87%2.75%2.63%2.65%2.49%2.49%2.44%2.34%2.52%2.87%3.29%3.39%3.19%4.01%4.57%4.43%-
Other Operating Expenses-600K0700K678.4M106.7M4.4M19M0-4M8.8M3.5M3.7M-1.65M-1.55M00-1.66M7K403K39.93M00000035.9M34.7M25.6M28.5M33M
Operating Income316.6M334.6M182.1M86.9M-211.7M137.1M24M235M-362.9M135.4M60.5M134.4M180.95M-118.26M124.71M155.59M-1.8M150.59M176.28M99.36M175.66M161.27M276.97M262.85M241.17M138.91M228.96M184.9M167.4M183.8M140.3M
Operating Margin %8.18%8.79%4.85%2.31%-6.12%3.51%0.61%5.33%-7.93%2.94%1.82%5.56%5.93%-4.14%4.17%5.49%-0.06%5.54%5.56%3.35%6.04%6.23%11.63%12.46%12.43%7.89%13.13%14.68%14.12%14.98%13.62%
Operating Income Growth %-83.75%109.55%141.05%-254.41%471.25%-89.79%164.76%-368.02%123.8%-54.99%-25.72%253.01%-194.83%-19.85%8734.52%-101.2%-14.57%77.42%-43.44%8.92%-41.77%5.37%8.99%73.62%-39.33%23.83%10.45%-8.92%31%31.37%
EBITDA410.4M462.1M314.4M213.3M-85.7M286.2M204.4M461.1M-115.1M387.6M195.3M198.4M255.02M-35.67M203.36M235.45M77.45M228.28M256.75M162.74M245.47M237.51M351.96M327.15M302.46M184.36M264.86M219.6M193M212.3M173.3M
EBITDA Margin %10.6%12.14%8.38%5.67%-2.48%7.33%5.24%10.46%-2.51%8.41%5.89%8.2%8.36%-1.25%6.8%8.3%2.74%8.4%8.1%5.49%8.45%9.18%14.78%15.51%15.59%10.47%15.19%17.44%16.28%17.3%16.82%
EBITDA Growth %18.24%46.98%47.4%348.89%-129.94%40.02%-55.67%500.61%-129.7%98.46%-1.56%-22.2%815.02%-117.54%-13.63%204%-66.07%-11.09%57.77%-33.7%3.35%-32.52%7.58%8.16%64.06%-30.39%20.61%13.78%-9.09%22.5%27.15%
D&A (Non-Cash Add-back)93.8M127.5M132.3M126.4M126M149.1M180.4M226.1M247.8M252.2M134.8M64M74.07M82.59M78.64M79.86M79.25M77.69M80.47M63.38M69.81M76.24M74.98M64.3M61.3M45.45M35.9M34.7M25.6M28.5M33M
EBIT248M207.3M202.6M148.6M-239.4M144.6M-2.7M-32.8M-323.4M-78.5M-141.8M134.4M196.81M-112.6M141.22M193.39M35.49M159.26M201.68M99.36M182.23M182.75M273.48M251.79M241.17M138.91M228.96M184.9M167.4M183.9M140.3M
Net Interest Income-79.9M-76.8M-143M-233.2M-189.2M-189.2M-266.6M-193.6M-146.2M-97M-79.9M-6.5M3.1M-29.2M-30.33M-34.46M-37.89M-35.45M-45.37M000000000000
Interest Income9.9M8.9M12.3M13M10M6.1M6.8M9.3M8.7M20.3M21.5M26M34.5M000000000000000000
Interest Expense89.8M85.7M155.3M246.2M199.2M195.3M273.4M202.9M154.9M117.3M101.4M32.5M31.4M29.23M30.33M34.46M37.89M35.45M45.25M000000000000
Other Income/Expense-155.4M-213M-132.3M1.37B-224.7M-187.5M-292.8M-462.9M-152.7M-98.4M-68.5M-12.8M-10.36M20.49M-7.29M8.8M-595K-26.79M-19.96M-24.02M-18.19M-352K-313K5.23M-22.62M-39.07M-24.6M16.5M-47.6M1.8M6.2M
Pretax Income161.2M121.6M49.8M1.45B-436.4M-50.4M-268.8M-227.9M-515.6M-191.9M-238.3M45.8M170.59M-119.81M117.43M164.39M-2.4M123.81M138.96M75.34M124.45M138.25M268.94M257.02M218.55M99.84M204.36M201.4M119.8M185.6M146.5M
Pretax Margin %4.16%3.2%1.33%38.62%-12.61%-1.29%-6.89%-5.17%-11.26%-4.16%-7.19%1.89%5.59%-4.19%3.93%5.8%-0.08%4.55%4.38%2.54%4.28%5.34%11.3%12.18%11.26%5.67%11.72%15.99%10.1%15.13%14.22%
Income Tax46.4M24.1M64.3M75.7M149.2M27.7M-1M116.7M37.2M28.3M-67.6M-13.7M53.57M56.72M29.91M12.81M14.56M44.48M32.55M35.8M37.9M55.35M84.99M82.25M86.25M32.95M67.44M72.5M43.7M63.1M49.1M
Effective Tax Rate %28.78%19.82%129.12%5.21%-34.19%-54.96%0.37%-51.21%-7.21%-14.75%28.37%-29.91%31.4%-47.34%25.47%7.8%-607.47%35.92%23.42%47.52%30.46%40.03%31.6%32%39.46%33%33%36%36.48%34%33.52%
Net Income111.2M94.6M-16.5M1.38B-581.4M-78.8M-269.1M-341.3M-568.7M-241.5M-178M76.8M114.42M-181.6M78.45M144.81M-20.25M41.61M93.46M39.54M86.55M96.75M183.96M174.78M99.15M66.89M136.92M128.9M76.1M122.5M97.4M
Net Margin %2.87%2.49%-0.44%36.59%-16.8%-2.02%-6.9%-7.74%-12.42%-5.24%-5.37%3.17%3.75%-6.36%2.62%5.11%-0.72%1.53%2.95%1.33%2.98%3.74%7.73%8.28%5.11%3.8%7.85%10.24%6.42%9.98%9.45%
Net Income Growth %962.02%673.33%-101.2%336.69%-637.82%70.72%21.15%39.99%-135.49%-35.67%-331.77%-32.88%163%-331.48%-45.82%815.07%-148.67%-55.48%136.36%-54.31%-10.54%-47.41%5.25%76.27%48.23%-51.14%6.22%69.38%-37.88%25.77%27.82%
Net Income (Continuing)114.8M97.5M-14.5M1.38B-585.6M-78.1M-267.8M-344.6M-528.7M-213.9M-179.3M59.5M107.3M-190.2M87.52M151.58M-16.96M79.33M114.82M47.91M93.14M89.73M181.81M171.27M132.3M66.89M136.92M128.9M76.1M122.5M97.4M
Discontinued Operations0000000000015.9M000523K000011.41M2.23M1.99M00000000
Minority Interest7.3M4.9M8.4M15.4M9.8M8.1M14.6M44.9M157.2M528.9M477.5M23.1M23.29M24.05M35.35M31.27M28.66M25.65M17.66M13.76M27.35M21.55M25.53M20.35M14.32M9.38M5.26M4.4M3.7M16.9M13.1M
EPS (Diluted)3.152.54-0.4421.38-7.44-1.00-3.47-4.51-7.48-3.20-2.581.121.76-2.851.232.24-0.310.621.410.591.551.432.532.371.370.931.921.851.101.761.42
EPS Growth %1000%677.27%-102.06%387.37%-644%71.18%23.06%39.71%-133.75%-24.03%-330.36%-36.36%161.75%-331.71%-45.09%822.58%-150%-56.03%138.98%-61.94%8.39%-43.48%6.75%72.99%47.31%-51.56%3.78%68.18%-37.5%23.94%-14.97%
EPS (Basic)-2.57-0.4421.38-7.44-1.00-3.47-4.51-7.48-3.20-2.581.141.77-2.851.242.25-0.310.631.410.601.571.452.552.391.380.941.921.861.101.781.42
Diluted Shares Outstanding35.3M37.2M37.6M64.36M79M78.3M77.6M76.7M76M75.5M69.1M65.6M65.15M63.66M63.91M64.79M65.91M66.87M66.49M66.67M67.25M71.34M72.53M72.92M72.3M71.78M71.48M69.56M69.31M69.6M68.8M
Basic Shares Outstanding34.4M36.8M37.6M64.36M79M78.3M77.6M76.7M76M75.5M69.1M64.9M64.53M63.66M63.06M64.24M65.91M66.26M66.08M65.84M66.67M70.58M72M72.42M71.98M71.52M71.3M69.36M68.96M68.82M68.8M
Dividend Payout Ratio-----------98.44%65.5%-92.83%50.34%-166.91%71.22%157.92%66.33%59.71%28.94%28.17%47.93%68.43%32.33%32.35%50.72%28.16%32.03%

Key Metrics

Growth RegimeStable
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Revenue growth remains sluggish

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Revenue Growth Remains Subdued

DBD's revenue growth has been modest, with Q2 2026 up only 1.7% year-over-year, and recent quarters showing negative growth, indicating a lack of momentum.

Revenue growth has been inconsistent, with Q2 2026 showing a 1.7% increase, but Q1 2026 and Q2 2025 saw declines of 6.0% and 2.6% respectively. This suggests that the company is struggling to achieve sustained top-line expansion, possibly due to market saturation or competitive pressures. The modest growth in Q2 2026 may be a temporary rebound rather than a durable trend, and investors should monitor whether the company can achieve consistent positive growth.

Gross Margin Shows Slight Improvement

Gross margin improved to 25.7% in Q2 2026 from 25.3% in Q1 2026, but remains below the 27.1% peak in Q4 2025, indicating limited pricing power.

Gross margin has been relatively stable in the mid-20s, with a slight uptick in Q2 2026. However, the margin is still below the 27.1% achieved in Q4 2025, suggesting that the company has not been able to fully pass on costs or improve product mix. The modest improvement may be due to cost controls, but the lack of significant expansion indicates that DBD faces competitive pricing pressures in its markets.

Operating Leverage Appears Limited

Operating income in Q2 2026 was $57.4M, roughly flat versus Q1 2026, despite a 4.4% revenue increase, indicating limited operating leverage.

The increase in revenue from Q1 to Q2 2026 did not translate into higher operating income, as it remained nearly unchanged. This suggests that variable costs are consuming the incremental revenue, or that SG&A expenses are not scaling down proportionally. The operating margin of 6.2% in Q2 2026 is below the 7.8% in Q3 2025, indicating that the company is not achieving economies of scale.

Earnings Quality Boosted by One-Time Items

Net income in Q4 2025 jumped to $49.6M with EPS of $1.37, but this appears to be an outlier, as other quarters show much lower or negative earnings.

The Q4 2025 net income of $49.6M is significantly higher than any other quarter in the dataset, suggesting that it may include one-time gains or tax benefits. In contrast, Q1 2025 and Q3 2024 reported net losses. This volatility in earnings raises questions about the sustainability of profitability, and investors should scrutinize the components of net income to assess the quality of earnings.

SG&A Fluctuates, R&D Stable

SG&A expenses were $162.3M in Q2 2026, up from $157.2M in Q1 2026, while R&D remained around $20-22M, indicating cost discipline in R&D but variability in SG&A.

R&D spending has been relatively stable, ranging from $20.3M to $25.6M over the past ten quarters, suggesting a consistent investment in product development. However, SG&A has fluctuated, with some quarters showing zero SG&A (likely due to data unavailability) and others showing over $160M. The increase in SG&A in Q2 2026 may be due to higher selling or administrative costs, which could pressure margins if not accompanied by revenue growth.

Q4 2025 Marks a Profitability Inflection

Q4 2025 saw a dramatic jump in operating income to $127.6M and net income to $49.6M, a clear inflection from prior quarters, likely driven by one-time factors.

The Q4 2025 results stand out as a significant improvement, with operating margin reaching 11.6% and net margin 4.5%, far above the typical 5-8% operating margin seen in other quarters. This inflection may be due to cost restructuring, favorable contract terms, or one-time gains. However, the subsequent quarters have not sustained this level, indicating that the Q4 2025 performance may not be repeatable.

What Could Invalidate the Base Case

The Q4 2025 earnings spike may mask underlying weakness, as revenue growth remains tepid and margins are below peer levels, suggesting potential overvaluation.

Short-sellers might argue that the Q4 2025 profitability is unsustainable, given that subsequent quarters show a reversion to lower margins and earnings. Additionally, DBD's gross margin of 25.7% is only slightly above NCR Atleos's 24.4%, but its operating margin of 6.2% is well below NCR's 11.0%, indicating operational inefficiencies. If revenue growth continues to stagnate and cost pressures persist, the market may reassess DBD's earnings power, leading to multiple compression.

DBD — Frequently Asked Questions

Quick answers to the most common questions about buying DBD stock.

What was Diebold Nixdorf, Incorporated's (DBD) revenue in 2025?

For fiscal year 2025, Diebold Nixdorf, Incorporated (DBD) reported total revenue of $3.81B. This represents a 269.4% increase compared to $1.03B in 1996.

Is Diebold Nixdorf, Incorporated (DBD) profitable?

Diebold Nixdorf, Incorporated (DBD) is profitable, generating $94.6M in net income for the fiscal year ending 2025 with a net profit margin of 2.5%.

What is Diebold Nixdorf, Incorporated's operating profit margin?

Diebold Nixdorf, Incorporated (DBD) reported an operating income of $334.6M, resulting in an operating profit margin of 8.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Diebold Nixdorf, Incorporated's gross profit and gross margin?

Diebold Nixdorf, Incorporated (DBD) generated $1.00B in gross profit for the year, representing a gross profit margin of 26.4%. This demonstrates the company's core pricing power and production efficiency.